Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Graft Polymer (UK) PLC ( (GB:SVNS) ) is now available.
Solvonis Therapeutics PLC, a UK-based company, has undergone a change in its major holdings due to an acquisition or disposal of financial instruments by Spreadex LTD. The notification reveals that Spreadex LTD now holds a total of 7.1213% of voting rights in Solvonis, up from a previous 6.9689%, indicating a slight increase in their stake. This change in holdings may impact the company’s market position and influence shareholder dynamics.
More about Graft Polymer (UK) PLC
YTD Price Performance: -17.07%
Average Trading Volume: 12,223,897
Technical Sentiment Signal: Strong Buy
Current Market Cap: £3.9M
See more data about SVNS stock on TipRanks’ Stock Analysis page.